The AGTR1 gene plays a crucial role in the regulation of blood pressure and fluid balance in the body, and mutations in this gene can lead to a rare, severe condition known as renal tubular dysgenesis (RTD). RTD is characterized by poor development of the kidney's tubules, leading to life-threatening complications shortly after birth, including an inability to produce urine (anuria), low blood pressure, and respiratory distress.
To diagnose this condition, a genetic test targeting the AGTR1 gene can be performed. This test is particularly vital for families with a history of RTD or for newborns showing symptoms consistent with the disorder. By analyzing the DNA sequence of the AGTR1 gene, the test can identify mutations that are known to cause RTD, providing crucial information for diagnosis, management, and genetic counseling.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test for AGTR1 gene mutations. The cost of the test is 4400 AED. Conducting the test at DNA Labs UAE ensures that patients and their families have access to cutting-edge genetic testing technology, expert analysis, and comprehensive support throughout the testing process. The results from this test can help guide clinical decisions, including potential treatments and interventions to manage the symptoms associated with RTD, and offer families vital information about the genetic risk of RTD in future pregnancies.
The REN Gene Renal Tubular Dysgenesis Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the REN gene, which are known to cause Renal Tubular Dysgenesis (RTD). RTD is a rare, severe disorder characterized by abnormal development of the kidneys' tubular system, leading to life-threatening conditions shortly after birth. This genetic test is crucial for early detection and understanding the genetic basis of the condition, enabling informed medical decisions and counseling for affected families.
The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific mutations in the REN gene that are linked to RTD. This analysis helps in confirming the diagnosis, understanding the disease's inheritance pattern, and assessing the risk for future pregnancies in the family.
The cost of the REN Gene Renal Tubular Dysgenesis Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, it represents a vital investment in the health and well-being of patients suspected of having RTD, offering a pathway towards precise diagnosis and potential treatment options.
The "CEP290 Gene Senior-Loken Syndrome Type 6 Genetic Test" is a specific diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the CEP290 gene, which are known to cause Senior-Loken syndrome type 6. This rare genetic disorder is characterized by a combination of nephronophthisis, a kidney disease leading to chronic renal failure, and retinitis pigmentosa, an eye disease that causes progressive vision loss. The test plays a crucial role in the early detection and management of the syndrome, enabling healthcare providers to offer targeted treatments and interventions to improve the quality of life for affected individuals. Priced at 4400 AED, this genetic test is a valuable tool for families with a history of the syndrome, offering them crucial information about their genetic status and the risk of passing the condition to their offspring. DNA Labs UAE ensures a comprehensive analysis with reliable results, aiding in the accurate diagnosis of Senior-Loken syndrome type 6.
The SDCCAG8 Gene Senior-Loken Syndrome Type 7 Genetic Test is a specific diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SDCCAG8 gene, which are known to cause Senior-Loken Syndrome type 7 (SLSN7). Senior-Loken Syndrome is a rare genetic disorder that combines kidney disease, specifically nephronophthisis, with retinal dystrophy, leading to progressive loss of kidney function and visual impairment. The test is crucial for individuals with a clinical history or family history of the condition, providing essential information for accurate diagnosis, management, and understanding the risk of passing the condition to offspring. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to detect any mutations in the SDCCAG8 gene, offering a reliable assessment for those suspected of having or being carriers of Senior-Loken Syndrome type 7. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, patients are assured of precise and confidential results, facilitating informed decisions about their health and future.
The PRSS2 gene plays a significant role in the pancreas, encoding a protease enzyme involved in the digestion of proteins. Mutations in this gene can influence the risk of developing pancreatitis, a condition characterized by inflammation of the pancreas. Chronic pancreatitis is a long-standing inflammation that can lead to permanent damage and affect the organ's ability to function properly, causing severe pain and digestive problems.
Understanding the genetic predisposition to pancreatitis can be crucial in managing and preventing the condition. This is where the "PRSS2 Gene Pancreatitis Chronic Protection Against Genetic Test" comes into play. Offered by DNA Labs UAE, this genetic test specifically looks for variations in the PRSS2 gene that are associated with a reduced or increased risk of developing chronic pancreatitis.
The test, priced at 4400 AED, is a valuable tool for individuals with a family history of pancreatitis or those who have experienced episodes of acute pancreatitis without a clear cause. By identifying genetic risk factors, healthcare providers can tailor prevention strategies and treatments to the individual's genetic makeup, potentially reducing the risk of progressing to chronic pancreatitis.
Conducted in the advanced facilities of DNA Labs UAE, the test involves a simple and non-invasive sample collection process. Results from the test can offer crucial insights into an individual's genetic predisposition to pancreatitis, empowering them with the knowledge to make informed decisions about their health and lifestyle choices to mitigate the risk of developing chronic pancreatitis.
The "SOX3 Gene Panhypopituitarism X-Linked Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the SOX3 gene, which are associated with X-linked panhypopituitarism. Panhypopituitarism is a condition characterized by the insufficient production of hormones by the pituitary gland, affecting various bodily functions. This condition can have genetic roots, particularly linked to abnormalities in the SOX3 gene located on the X chromosome. Identifying mutations in this gene is crucial for confirming the diagnosis, understanding the condition's inheritance pattern, and guiding treatment decisions.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab to identify any genetic alterations in the SOX3 gene that may be responsible for the development of panhypopituitarism. This test is particularly important for families with a history of the condition, as it can help in early diagnosis and management in affected individuals.
At DNA Labs UAE, the cost for the SOX3 Gene Panhypopituitarism X-Linked Genetic Test is 4400 AED. This price includes the full process of sample collection, genetic analysis, and a comprehensive report detailing the findings. The test is performed by experienced professionals using the latest genetic testing technologies to ensure accurate and reliable results. Families and individuals opting for this test can gain valuable insights into their genetic health, allowing for informed medical decisions and personalized care plans.
The CDC73 gene test for parathyroid adenoma with cystic changes is a specialized genetic analysis aimed at identifying mutations in the CDC73 gene, which are often linked to the development of parathyroid adenomas, a type of noncancerous tumor of the parathyroid glands. These glands are crucial for calcium homeostasis in the body. Mutations in the CDC73 gene can lead to familial hyperparathyroidism or the isolated occurrence of parathyroid tumors, sometimes presenting with cystic changes. Identifying mutations in this gene can help in diagnosing the condition, guiding treatment options, and assessing the risk of disease in family members.
The test is available at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the CDC73 gene test for parathyroid adenoma with cystic changes is 4400 AED. This test is particularly valuable for individuals with a family history of parathyroid disorders or those who have clinical symptoms suggestive of a parathyroid adenoma, as it provides crucial information for managing the condition effectively.
The SLC26A4 gene plays a critical role in the body, and mutations in this gene are associated with Pendred syndrome, a genetic disorder that can lead to hearing loss and thyroid problems. To diagnose this condition, the SLC26A4 Gene Pendred Syndrome Genetic Test is available at DNA Labs UAE. This test is specifically designed to identify mutations in the SLC26A4 gene, providing crucial information for the diagnosis and management of Pendred syndrome.
The test is conducted using a sample of the patient's DNA, typically extracted from a blood sample. It involves sophisticated genetic sequencing techniques to examine the SLC26A4 gene for any abnormalities that could indicate the presence of Pendred syndrome. This genetic testing is crucial for individuals showing symptoms of the syndrome or those with a family history of genetic disorders, as it can help in early diagnosis and intervention.
The cost of the SLC26A4 Gene Pendred Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the collection of the sample, the genetic analysis, and the provision of a detailed report by the laboratory's genetic experts. The report not only identifies the presence of any mutations in the SLC26A4 gene but also offers insights into the implications of these genetic findings for the patient's health and any potential treatment or management strategies.
Given the complexity of genetic disorders like Pendred syndrome, the availability of this test represents a significant step forward in personalized medicine, allowing for tailored interventions that can improve patient outcomes.
The PRKAR1A Gene Pigmented Nodular Adrenocortical Disease Type 1 Primary Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is specifically designed to detect mutations in the PRKAR1A gene, which are known to cause Pigmented Nodular Adrenocortical Disease Type 1 (PNDAD1), a rare form of adrenal gland disorder characterized by the development of small, pigmented nodules within the adrenal cortex leading to an overproduction of cortisol. This condition is also associated with Carney complex, a genetic syndrome that affects multiple systems in the body and increases the risk of developing various types of tumors.
The test is crucial for individuals suspected of having PNDAD1 or those with a family history of Carney complex, as early detection can significantly influence management and treatment strategies. By analyzing the patient's DNA, the test can identify specific genetic alterations in the PRKAR1A gene, confirming the diagnosis and enabling personalized treatment plans.
The cost of the PRKAR1A Gene Pigmented Nodular Adrenocortical Disease Type 1 Primary Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the condition and the specialized nature of the test, the price reflects the comprehensive analysis and the valuable insights it provides for affected individuals and their families. Undergoing this test at DNA Labs UAE ensures access to cutting-edge genetic testing technologies and expert interpretation of results, contributing to effective management of the condition.
The LHX3 Gene Pituitary Hormone Deficiency Combined Type 3 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the LHX3 gene that are associated with Combined Pituitary Hormone Deficiency (CPHD) Type 3. This condition is characterized by a significant reduction or complete absence of one or more pituitary hormones, which can lead to various health issues, including growth hormone deficiency, thyroid hormone deficiency, and adrenal insufficiency, among others. The test plays a crucial role in the early diagnosis and management of the condition, enabling personalized treatment plans that can significantly improve the quality of life for affected individuals. Priced at 4400 AED, this genetic test offers a valuable resource for patients and healthcare providers in identifying and addressing this complex disorder with precision and tailored care.
